New Investigator Committee

The ISH New Investigator Committee (NIC) is charged with the day to day running of the New Investigators Network. It encourages and supports initiatives to attract and retain younger members of the ISH. Four Working Groups were established to work alongside this committee and further develop interactions with hypertension future leaders.

• 

  Maciej Tomaszewski Chair

  UK

  My research interests focus primarily on genetics and genomics of cardiovascular disorders with a particular emphasis on essential hypertension and its complications.

  I am also interested in genetic and environmental background of sexual dimorphism in cardiovascular risk (why men develop and die of cardiovascular disorders more frequently than age-matched women).

• 

  Dylan Burger Member

  Canada

  My research focuses on the cellular mechanisms of oxidative stress, inflammation and vascular dysfunction in hypertension. I have a particular interest in the role of microparticles, tiny cellular fragments shed from stressed cells of the vasculature, in hypertension and vascular disease.

• 

  Fadi Charchar Member

  Australia

  My research interests focus on genomics of cardiovascular disease in humans and animal models. I have a special interest in the contribution of the Y chromosome and microRNA to hypertension.

• 

  Alta Schutte New Investigator Committee Liaison Officer

  South Africa

  As the Research Chair in Chronic Diseases in South Africa, my research spans clinical and epidemiological population studies focusing on the development of hypertension in African communities. By using longitudinal transdisciplinary research programmes I aim to identify novel markers and/or bio-signatures as early predictors of vascular dysfunction in an attempt to contribute to the prevention of hypertension.

• 

  Praveen Veerabhadrappa Member

  U.S.A.

  My research is focused on the Blood Pressure-measurement/monitoring (ABPM) and the effects of lifestyle modification on endothelial cell function (FMD/IMT) and vascular inflammatory biomarkers in hypertensive subjects.